Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Seattle Genetics Inc.
DescriptionAntibody drug conjugate (ADC) for multiple myeloma targeting CD352
Molecular Target
Mechanism of ActionAntibody-drug conjugate
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple myeloma (MM)
Indication DetailsMultiple myeloma (MM)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today